FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

22231011000036108: chloral hydrate 23 mg / 1 g + menthol 46 mg / 1 g + methyl salicylate 96 mg / 1 g + zinc oxide 64 mg / 1 g ointment (medicinal product unit of use)


Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
287657011000036115 chloral hydrate 23 mg / 1 g + menthol 46 mg / 1 g + methyl salicylate 96 mg / 1 g + zinc oxide 64 mg / 1 g ointment (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
287658011000036119 methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment en Synonym Active Case sensitive Australian Medicines Terminology module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment Is a medicinal product unit of use true Inferred relationship Some
methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment Is a methyl salicylate + menthol + chloral hydrate + zinc oxide true Inferred relationship Some
methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment has intended active ingredient menthol true Inferred relationship Some 195482072
methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment has Australian BoSS menthol true Inferred relationship Some 195482072
methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment has intended active ingredient chloral hydrate true Inferred relationship Some 589977848
methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment has Australian BoSS chloral hydrate true Inferred relationship Some 589977848
methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment has intended active ingredient zinc oxide true Inferred relationship Some 530647672
methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment has Australian BoSS zinc oxide true Inferred relationship Some 530647672
methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment has intended active ingredient methyl salicylate true Inferred relationship Some 353606312
methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment has Australian BoSS methyl salicylate true Inferred relationship Some 353606312
methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment has manufactured dose form ointment true Inferred relationship Some
methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment has unit of use continuous true Inferred relationship Some 589977849

Inbound Relationships Type Active Source Characteristic Refinability Group
Methyl Salicylate Compound (Gold Cross) ointment Is a True methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment Inferred relationship Some
methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment, 100 g has MPUU True methyl salicylate 9.6% + menthol 4.6% + chloral hydrate 2.3% + zinc oxide 6.4% ointment Inferred relationship Some 1

Reference Sets

List of Excluded Medicinal Items reference set

Medicinal product unit of use reference set

Back to Start